Three-dimensional quantitative muscle ultrasound in patients with facioscapulohumeral dystrophy and myotonic dystrophy

被引:4
|
作者
de Jong, Leon [1 ]
Greco, Anna [2 ]
Nikolaev, Anton [1 ]
Weijers, Gert [1 ]
van Engelen, Baziel G. M. [2 ]
de Korte, Chris L. L. [1 ]
Futterer, Jurgen J. J. [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Dept Med Imaging, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands
基金
欧盟地平线“2020”;
关键词
diagnostic criteria; FSHD; muscle ultrasound; myotonic dystrophy; quantitative ultrasound; three-dimensional ultrasound;
D O I
10.1002/mus.27943
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction/AimsUltrasound imaging of muscle tissue conventionally results in two-dimensional sampling of tissue. For heterogeneously affected muscles, a sampling error using two-dimensional (2D) ultrasound can therefore be expected. In this study, we aimed to quantify and extend ultrasound imaging findings in neuromuscular disorders by using three-dimensional quantitative muscle ultrasound (3D QMUS). MethodsPatients with facioscapulohumeral dystrophy (n = 31) and myotonic dystrophy type 1 (n = 16) were included in this study. After physical examination, including Medical Research Council (MRC) scores, the tibialis anterior muscle was scanned with automated ultrasound. QMUS parameters were calculated over 15 cm of the length of the tibialis anterior muscle and were compared with a healthy reference data set. ResultsWith 3D QMUS local deviations from the healthy reference could be detected. Significant Pearson correlations (P < .01) between MRC score and QMUS parameters in male patients (n = 23) included the mean echo intensity (EI) (0.684), the standard deviation of EI (0.737), and the residual attenuation (0.841). In 91% of all patients, mean EI deviated by more than 1 standard deviation from the healthy reference. In general, the proportion of muscle tissue with a Z score >1 was about 50%. DiscussionIn addition to mean EI, multiple QMUS parameters reported in this study are potential biomarkers for pathology. Besides a moderate correlation of mean EI with muscle weakness, two other parameters showed strong correlations: standard deviation of EI and residual attenuation. Local detection of abnormalities makes 3D QMUS a promising method that can be used in research and potentially for clinical evaluation.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 50 条
  • [21] Masticatory muscle activity in myotonic dystrophy patients
    Odman, C
    Kiliaridis, S
    JOURNAL OF ORAL REHABILITATION, 1996, 23 (01) : 5 - 10
  • [22] Symptom Burden in Persons with Myotonic and Facioscapulohumeral Muscular Dystrophy
    Smith, Amanda E.
    McMullen, Kara
    Jensen, Mark P.
    Carter, Gregory T.
    Molton, Ivan R.
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2014, 93 (05) : 387 - 395
  • [23] Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy
    Hauerslev, S.
    Orngreen, M. C.
    Hertz, J. M.
    Vissing, J.
    Krag, T. O.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (03): : 194 - 201
  • [24] Three-dimensional assessment of pharyngeal airway in individuals with myotonic dystrophy type 1
    Evlice, Burcu
    Koc, Filiz
    Duyan, Hazal
    Cabuk, Damla Soydan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (06) : 3022 - 3029
  • [25] Analysis of skeletal muscle from patients with facioscapulohumeral dystrophy
    Rogers, MT
    Sewry, CA
    Oversby, A
    James, VEM
    Anderson, LVB
    Jasani, B
    Neal, JW
    Newman, GR
    Bushby, KMD
    Harper, PS
    NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 633 - 633
  • [26] Quantitative muscle magnetic resonance imaging in patients with myotonic dystrophy type 1
    Marty, B.
    Le Louer, J.
    Canal, A.
    Hogrel, J. Y.
    Gyenge, M.
    Jebrouni, N.
    Reyngoudt, H.
    Bassez, G.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S115 - S116
  • [27] SUPRASPINATUS MUSCLE BIOPSY IN FACIOSCAPULOHUMERAL DYSTROPHY
    JARRELL, HR
    SCHOCHET, SS
    BODENSTEINER, JB
    CLINICAL RESEARCH, 1981, 29 (05): : A892 - A892
  • [28] Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy
    Vincenten, S. C. C.
    Teeselink, S.
    Voermans, N. C.
    van Engelen, B. G. M.
    Mul, K.
    van Alfen, N.
    NEUROMUSCULAR DISORDERS, 2023, 33 (12) : 936 - 944
  • [29] Facioscapulohumeral muscle dystrophy and heart disease
    Emmrich, P
    Ogunlade, V
    Gradistanac, T
    Daneschnejad, S
    Koch, MC
    Schober, R
    ZEITSCHRIFT FUR KARDIOLOGIE, 2005, 94 (05): : 348 - 354
  • [30] Muscle microdialysis in facioscapulohumeral muscular dystrophy
    Tasca, G.
    Monforte, M.
    Corbi, M.
    Granata, G.
    Sgambato, A.
    Ricci, E.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S169 - S169